摘要
目的分析依达拉奉治疗急性脑梗死的临床疗效。方法将85例患者随机分为两组,对照组40例经常规治疗,治疗组45例经常规治疗联合依达拉奉治疗。结果治疗组治疗后NIHSS评分较对照组降低,ADL评分较对照组提高,P<0.05。结论依达拉奉治疗急性脑梗死临床疗效显著。
Objective To analyze the adr in the clinical curative effect of treatment of acute cerebral infarction. Methods 85 patients were randomly divided into two groups, control group 40 cases with conventional treatment, the treatment group 45 cases of edaravone mentioned by conventional treatment combined treatment. Results The treatment group after treatment NIHSS score significantly lower than the control group, ADL scores than the control group increased obviously, P〈0.05. Conclusion Edaravone in treatment of acute cerebral infarction clinical curative effect is distinct.
出处
《中国继续医学教育》
2015年第21期176-177,共2页
China Continuing Medical Education
关键词
依达拉奉
急性脑梗死
临床疗效
Edaravone
Acute cerebral infarction
Clinical curative effect
